Competition law has again worked to fight a bad drug patent, but we need other solutions

A Competition Commission probe recently resulted in a patent on an important tuberculosis medicine being dropped in South Africa. Twenty years ago, a similar Competition Commission case resulted in a settlement that helped drive down the prices of several antiretrovirals, thereby helping to set the stage for the country’s HIV treatment programme. Fatima Hassan and Leena Menghaney connect the dots between the two landmark cases and map out what has and has not changed over the last two decades.

Read More

Mabuyane under fire for moving Eastern Cape head of health

Some health activists and health professionals this week slammed as disruptive and nonsensical Eastern Cape Premier Oscar Mabuyane’s decision to ‘second’ the head of health in the province, Dr Rolene Wagner, to a special unit in his office. Many have expressed concern over the impact this may have on providing health services, but Mabuyane insists his decision will not impact service delivery. Luvuyo Mehlwana reports.

Read More

Analysis: Landmark SA court case takes on US maker of cystic fibrosis drugs

Cystic fibrosis (CF) is a debilitating and often deadly disease. Until recently, the only treatments for its symptoms were difficult to administer and time-consuming. Life-changing new treatments that dramatically improve the prognosis for people with the disease have been developed, but they are expensive and Vertex, the US company making the drugs, has decided against registering the drugs in South Africa. Cheri Nel, a woman living with CF, is now taking Vertex on in a South African court. Catherine Tomlinson unpacks the details.

Read More

OPINION: How can we make surgical care accessible by drawing on lessons from the AIDS movement?

The quest for access to equitable and quality surgical care for all will not be won only in board rooms, theatres, or hospital corridors. We have to take this quest into communities and build alliances. In that respect, we can learn from one of the best examples of how community participation and mobilisation can help change health policy – the movement to ensure access to affordable and universal anti-retroviral treatment for persons living with HIV, argues Professor Kathryn Chu and Sangeun Lee.

Read More

ANALYSIS: Mixed feelings about NHI at public health conference

National Health Insurance (NHI) was one of the hot topics at the 2022 Public Health Association of South Africa Conference recently held in Durban. While several speakers and attendees expressed support for the principles underpinning NHI, many also expressed reservations. Elri Voigt assesses what the conference told us about the views of some of South Africa’s public health experts on NHI.

Read More

“It took me three seconds to decide” – Fareed Abdullah reflects on his career in public health

Over the last three decades, Dr Fareed Abdullah has been at the coalface of South Africa’s response to HIV, tuberculosis, and more recently, COVID-19. Biénne Huisman chatted with Abdullah about providing antiretrovirals in the time of AIDS denialism, National Health Insurance, working as a medical doctor, and the toll HIV has sadly taken on his own family.

Read More